W. J. Guan, Z. Y. Ni, Y. Hu, W. H. Liang, C. Q. Ou et al., Clinical Characteristics of Coronavirus Disease 2019 in China, New England Journal of Medicine, vol.382, issue.18, pp.1708-1720, 2020.

F. Wu, S. Zhao, B. Yu, Y. M. Chen, W. Wang et al., A new coronavirus associated with human respiratory disease in China, Nature, vol.579, issue.7798, pp.265-269, 2020.

N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang et al., A Novel Coronavirus from Patients with Pneumonia in China, 2019, New England Journal of Medicine, vol.382, issue.8, pp.727-733, 2020.

F. X. Lescure, L. Bouadma, D. Nguyen, M. Parisey, P. H. Wicky et al., Clinical and virological data of the first cases of COVID-19 in Europe: a case series, The Lancet Infectious Diseases, vol.20, issue.6, pp.697-706, 2020.
URL : https://hal.archives-ouvertes.fr/inserm-02549694

R. Wölfel, V. M. Corman, W. Guggemos, M. Seilmaier, S. Zange et al., Virological assessment of hospitalized patients with COVID-2019, Nature, vol.581, issue.7809, pp.465-469, 2020.

L. Guo, L. Ren, S. Yang, M. Xiao, D. M. Chang et al., Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19), Clinical Infectious Diseases, vol.71, issue.15, pp.778-785, 2020.

A. T. Huang, B. Garcia-carreras, M. D. Hitchings, B. Yang, L. C. Katzelnick et al., A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease, 2020.

E. P. Coutant, G. Gagnot, V. Hervin, R. Baatallah, S. Goyard et al., Bioluminescence Profiling of NanoKAZ/NanoLuc Luciferase Using a Chemical Library of Coelenterazine Analogues, Chemistry ? A European Journal, vol.26, issue.4, pp.948-958, 2020.

E. P. Coutant, S. Goyard, V. Hervin, G. Gagnot, R. Baatallah et al., Gram-scale synthesis of luciferins derived from coelenterazine and original insights into their bioluminescence properties, Organic & Biomolecular Chemistry, vol.17, issue.15, pp.3709-3713, 2019.
URL : https://hal.archives-ouvertes.fr/pasteur-02072739

S. Goyard, B. Balbino, R. S. Chinthrajah, S. C. Lyu, Y. L. Janin et al., A highly sensitive bioluminescent method for measuring allergen?specific IgE in microliter samples, Allergy, vol.75, issue.11, pp.2952-2956, 2020.
URL : https://hal.archives-ouvertes.fr/pasteur-02949568

L. Grzelak, S. Temmam, C. Planchais, C. Demeret, L. Tondeur et al., A comparison of four serological assays for detecting anti?SARS-CoV-2 antibodies in human serum samples from different populations, Science Translational Medicine, vol.12, issue.559, p.eabc3103, 2020.

. Spf, La santé publique en France à l?épreuve de la COVID-19, Santé Publique, vol.32, issue.1, p.5, 2020.

A. L. Garcia-basteiro, G. Moncunill, M. Tortajada, M. Vidal, C. Guinovart et al., Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital, Nature Communications, vol.11, issue.1, p.3500, 2020.

J. J. Grant, S. M. Wilmore, N. S. Mccann, O. Donnelly, R. W. Lai et al., Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust, Infection Control & Hospital Epidemiology, pp.1-3, 2020.

J. Korth, B. Wilde, S. Dolff, O. E. Anastasiou, A. Krawczyk et al., SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients, Journal of Clinical Virology, vol.128, p.104437, 2020.

M. Plebani, A. Padoan, U. Fedeli, E. Schievano, E. Vecchiato et al., SARS-CoV-2 serosurvey in health care workers of the Veneto Region, Clinical Chemistry and Laboratory Medicine (CCLM), vol.0, issue.0, 2020.

L. Valenti, A. Bergna, S. Pelusi, F. Facciotti, A. Lai et al., SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak, 2020.

P. Zhou, X. L. Yang, X. G. Wang, B. Hu, and L. Zhang, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, vol.579, pp.270-273, 2020.

D. F. Gudbjartsson, G. L. Norddahl, P. Melsted, K. Gunnarsdottir, H. Holm et al., Humoral Immune Response to SARS-CoV-2 in Iceland, New England Journal of Medicine, vol.383, issue.18, pp.1724-1734, 2020.

J. Rosado, S. Pelleau, C. Cockram, S. H. Merkling, N. Nekkab et al., Serological signatures of SARS-CoV-2 infection: Implications for antibody-based diagnostics, 2020.
URL : https://hal.archives-ouvertes.fr/pasteur-02569149

D. Sterlin, A. Mathian, M. Miyara, A. Mohr, F. Anna et al., IgA dominates the early neutralizing antibody response to SARS-CoV-2, 2020.

E. S. Rosenberg, J. M. Tesoriero, E. M. Rosenthal, R. Chung, M. A. Barranco et al., Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York, Ann Epidemiol, vol.48, pp.23-29, 2020.

S. Stringhini, A. Wisniak, G. Piumatti, A. S. Azman, S. A. Lauer et al., Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study, The Lancet, vol.396, issue.10247, pp.313-319, 2020.

X. Xu, J. Sun, S. Nie, H. Li, Y. Kong et al., Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China, Nature Medicine, vol.26, issue.8, pp.1193-1195, 2020.

M. F. Silveira, A. Barros, B. L. Horta, L. C. Pellanda, G. D. Victora et al., Repeated population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil, Nat Med, vol.26, pp.1196-1199, 2020.

V. Naranbhai, C. C. Chang, W. F. Beltran, T. E. Miller, M. G. Astudillo et al., High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts, The Journal of Infectious Diseases, 2020.

M. Gandhi and G. W. Rutherford, Facial Masking for Covid-19 ? Potential for ?Variolation? as We Await a Vaccine, New England Journal of Medicine, vol.383, issue.18, p.e101, 2020.

R. Li, S. Pei, B. S. Chen, Y. Song, T. Zhang et al., Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2), Science, vol.368, issue.6490, pp.489-493, 2020.

F. P. Havers, C. Reed, T. Lim, J. M. Montgomery, J. D. Klena et al., Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020, JAMA Internal Medicine, 2020.

J. Perez-saez, S. A. Lauer, L. Kaiser, S. Regard, E. Delaporte et al., Serology-informed estimates of SARS-COV-2 infection fatality risk in Geneva, Switzerland, Lancet Infect Dis, issue.20, pp.30584-30587, 2020.